Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in insulin- naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial-Reference-Cited by-同舟云学术

Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in insulin- naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial

Published:2017-09 Issue:4 Volume:43 Page:351-358
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Bolli G.B.,Riddle M.C.,Bergenstal R.M.,Wardecki M.,Goyeau H.,Home P.D.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference23 articles.

1. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

2. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem;Polonsky;Diabetes Care,2005

3. Factors associated with psychological insulin resistance in individuals with type 2 diabetes;Nam;Diabetes Care,2010

4. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study;Peyrot;Diabet Med,2012

5. New insulin glargine 300Units·mL−1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100Units·mL−1;Becker;Diabetes Care,2015

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traiter les hypoglycémies iatrogènes à l’ère des nouvelles technologies;Médecine des Maladies Métaboliques;2024-05

2. Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials;Frontiers in Endocrinology;2024-03-21

3. Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study;Advances in Therapy;2024-03-21

4. An exploratory analysis of the cost‐effectiveness of insulin glargine 300 units/mL versus insulin glargine 100 units/mL over a lifetime horizon using the BRAVO diabetes model;Diabetic Medicine;2024-03-12

5. Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes;JAMA;2023-07-18